Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Abstract
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acceso restringido / Suscripción (Metadatos de producción científica)